Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
parkinson's disease
abbvie
acorda therapeutics
ampyra
apokyn
apomorphine
bial
biotech
boston blog main
boston top stories
dalfampridine
drug development
duopa
fda
inbrija
mylan
national top stories
neurocrine
neurodegeneration
neuroscience
new york
new york blog main
new york top stories
opicapone
paul matteis
san diego
san diego blog main
san diego top stories
stiel
sunovion pharmaceuticals
What
disease
2
×
fda
gets
nod
2
×
parkinson’s
patients
acorda
add
approved
called
carbidopa
combination
control
cope
daily
drug
episodes
experience
friday
help
late
levodopa
looms
meant
medication
medications
neurocrine
new
pill
rival
stop
symptoms
time
treatment
working
Language
unset
Current search:
nod
×
disease
×
@xconomy.com
3 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms